ReviewFrontiers in oncology2026

Managing skin-related adverse events during mirdametinib treatment for NF1-PNs: expert guidance from the ReNeu trial.

Angela C Hirbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.